Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 8/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.71 |
| ▸ | HTT | P42858 | 3/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 5/20 | 0.63 |
| ▸ | DDX3X | O00571 | 1/20 | 0.63 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.60 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.60 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3217135 | 0.88 | MEN1 (0.64) | MEN1KMT2AHTTALDH1A1SMN1; SMN2 | |
| SCHEMBL13488642 | 0.86 | HTT (0.76) | MEN1KMT2AHTTALDH1A1SMN1; SMN2 | |
| SCHEMBL6159248 | 0.86 | MEN1 (0.80) | MEN1KMT2AHTTALDH1A1SMN1; SMN2 | |
| SCHEMBL10876285 | 0.85 | MEN1 (0.58) | MEN1KMT2AHTTALDH1A1SMN1; SMN2 | |
| SCHEMBL5141415 | 0.85 | MEN1 (0.75) | MEN1KMT2AHTTALDH1A1SMN1; SMN2 | |
| SCHEMBL4186398 | 0.84 | HTT (0.62) | MEN1KMT2AHTTALDH1A1SMN1; SMN2 | |
| SCHEMBL5213509 | 0.84 | CYP1A2 (0.78) | MEN1KMT2AHTTALDH1A1SMN1; SMN2 | |
| SCHEMBL30957465 | 0.84 | CYP1A2 (0.78) | MEN1KMT2AHTTALDH1A1SMN1; SMN2 | |
| SCHEMBL9495103 | 0.83 | SMN1; SMN2 (0.71) | MEN1KMT2AHTTALDH1A1SMN1; SMN2 | |
| SCHEMBL8752436 | 0.82 | SMN1; SMN2 (0.72) | MEN1KMT2AHTTALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113185417-B | Red base B separation process | 山东师范大学实验厂有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-113185417-A | Red base B separation process | 山东师范大学实验厂 | 2021-07-30 | — | — | CN | claimed |
| US-20240408064-A1 | RAS INHIBITORS, COMPOSITIONS AND METHODS OF USE THEREOF | GENETOLEAD INC. (CA) | 2024-12-12 | — | — | US | disclosed |
| WO-2023060362-A1 | RAS INHIBITORS, COMPOSITIONS AND METHODS OF USE THEREOF | GENETOLEAD INC. (CA) | 2023-04-20 | — | — | WO | disclosed |
| CN-113185417-B | Red base B separation process | 山东师范大学实验厂有限公司 | 2022-12-20 | — | — | CN | disclosed |
| CN-113185417-B | Red base B separation process | 山东师范大学实验厂有限公司 | 2022-12-20 | — | — | CN | disclosed |
| CN-113185417-A | Red base B separation process | 山东师范大学实验厂 | 2021-07-30 | — | — | CN | disclosed |
| CN-113185417-A | Red base B separation process | 山东师范大学实验厂 | 2021-07-30 | — | — | CN | disclosed |
| US-20080166310-A1 | Administration of 2-oxyacetamide compounds for promoting and/or inducing and/or stimulating the pigmentation of keratin materials and/or for limiting the depigmentation and/or bleaching thereof | L'OREAL (FR) | 2008-07-10 | — | — | US | disclosed |
| EP-1268487-B1 | TRICYCLIC PROTEIN KINASE INHIBITORS | WYETH CORP (US) | 2003-11-26 | — | — | EP | disclosed |
| US-6608048-B2 | Treatment of cancer, polycystic kidney disease and colonic polyps in mammals | WYETH HOLDINGS | 2003-08-19 | — | — | US | disclosed |
| US-5631209-A | ALGICIDES | ROHM AND HAAS COMPANY (US) | 1997-05-20 | — | — | US | disclosed |
| US-5502027-A | ALGICIDES | ROHM AND HAAS COMPANY (US) | 1996-03-26 | — | — | US | disclosed |
| EP-0415642-B1 | Glutarimides | ROHM & HAAS (US) | 1995-12-06 | — | — | EP | disclosed |
| US-5393735-A | N-(halo-oxy-)phenyl substituted cyclic imides | ROHM AND HAAS COMPANY (US) | 1995-02-28 | — | — | US | disclosed |
| EP-0415641-B1 | Substituted glutaramic acids and derivatives | ROHM & HAAS (US) | 1994-01-19 | — | — | EP | disclosed |
| US-5238908-A | HERBICIDAL GLUTARAMIC ACIDS AND DERIVATIVES | ROHM AND HAAS COMPANY (US) | 1993-08-24 | — | — | US | disclosed |
| EP-0415641-A1 | Substituted glutaramic acids and derivatives | ROHM AND HAAS COMPANY (US) | 1991-03-06 | — | — | EP | disclosed |
| EP-0415642-A1 | Glutarimides | ROHM AND HAAS COMPANY (US) | 1991-03-06 | — | — | EP | disclosed |
| US-4025642-A | ANTIALLERGENS | SMITHKLINE CORPORATION (US) | 1977-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240408064-A1 | RAS INHIBITORS, COMPOSITIONS AND METHODS OF USE THEREOF | KRAS, NRAS, HRAS | MEN1 671/4885KMT2A 2133/4885HTT 2241/4885 |
| US-20080166310-A1 | Administration of 2-oxyacetamide compounds for promoting and/or inducing and/or stimulating the pigmentation of keratin materials and/or for limiting the depigmentation and/or bleaching thereof | KRT18, TYR, CRYAA | MEN1 4421/4885KMT2A 82/4885HTT 2181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.